Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Medchemexpress LLC BMS-962212 10mg | 1430114-34-3 | C32H28ClFN8O5 | 10 MG
SDP

Catalog No. 5000226247
Encompass_Preferred

BMS-962212 is a reversible, direct, and selective small-molecule inhibitor of coagulation factor XIa (FXIa) used in research on anticoagulation and thrombosis. It produces dose-dependent increases in activated partial thromboplastin time (aPTT) and reductions in FXI clotting activity; molecular formula C32H28ClFN8O5, molecular weight 659.07 g·mol⁻1.

  • Reversible, selective FXIa inhibition for anticoagulation research.
  • Demonstrated dose-dependent pharmacodynamic effects on aPTT and FXI activity.
  • High reported purity (99.33%).
  • Offered in research sample quantities (10 MG).

Catalog No. 50-002-26247 Supplier Medchemexpress LLC Supplier No. HY11729010MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

BMS-962212 is a reversible, direct, and selective small-molecule inhibitor of coagulation factor XIa (FXIa) used in research on anticoagulation and thrombosis. It produces dose-dependent increases in activated partial thromboplastin time (aPTT) and reductions in FXI clotting activity; molecular formula C32H28ClFN8O5, molecular weight 659.07 g·mol⁻1.

  • Reversible, selective FXIa inhibition for anticoagulation research.
  • Demonstrated dose-dependent pharmacodynamic effects on aPTT and FXI activity.
  • High reported purity (99.33%).
  • Offered in research sample quantities (10 MG).

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.